Latest Breaking News On - Royalty repayment amount - Page 1 : comparemela.com
Form 10-K Jaguar Health, Inc For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Jaguar Health Signs Second Agreement for $6 Million Non-dilutive Financing Transaction Involving the Sale of Royalty Rights Related to Future Mytesi (Crofelemer) and Lechlemer Revenue Stream
albuquerqueexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albuquerqueexpress.com Daily Mail and Mail on Sunday newspapers.
(2)
No royalty payments due for 18-24 months
Proceeds will be allocated to support regulatory activities associated with the Company s development pipeline, including funding the recently initiated pivotal clinical trial for crofelemer (Mytesi
®) for cancer therapy-related diarrhea (CTD), for which patient enrollment is progressing
SAN FRANCISCO, CA / ACCESSWIRE / December 23, 2020 / Jaguar Health, Inc. (NASDAQ:JAGX) ( Jaguar or the Company ) today announced that the Company has signed an agreement (the Agreement ) with a secured lender (the Lender ) for a non-dilutive royalty financing transaction, pursuant to which Jaguar would sell to the Lender for an aggregate purchase price of $6 million (the Royalty Purchase Price ) a royalty interest entitling the Lender to receive 2.0x the Royalty Purchase Price of future royalties of Mytesi